D S Ettinger

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

Eric K. Rowinsky, L B Grochow, D S Ettinger et al. · PubMed · 1994 · 195 citations

Cpt Analogues, Pharmacotherapy, Metronomic Chemotherapy +16

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.

D S Ettinger, Dianne M. Finkelstein, Martin D. Abeloff et al. · Journal of Clinical Oncology · 1990 · 105 citations

Cancer Management, Pharmacotherapy, Metronomic Chemotherapy +18

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.

Douglas H. Johnson, Andrew T. Turrisi, A. Y. Chang et al. · Journal of Clinical Oncology · 1993 · 67 citations

The clinical significance of variant-morphology small-cell carcinoma of the lung.

Seena C. Aisner, Dianne M. Finkelstein, D S Ettinger et al. · Journal of Clinical Oncology · 1990 · 50 citations

Tumoral Pathology, Health Sciences, Malignant Disease +13

Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).

D A Noe, Eric K. Rowinsky, H S Shen et al. · PubMed · 1990 · 42 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmacokinetic Modeling +15